Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, works by slowing stomach emptying and signaling fullness to your brain—effects that require gradual dose increases over four months. Understanding how your dose progresses and why it matters can help you stay committed to your weight loss plan and manage expectations for results.

Standard Semaglutide Dosing Schedule and Titration Protocol

Most semaglutide programs begin with a 0.25 mg weekly injection during weeks 1–4, allowing your body to adapt to the medication. Your prescriber then increases your dose by 0.25 mg increments every four weeks: 0.5 mg in weeks 5–8, 0.75 mg in weeks 9–12, and 1.0 mg in weeks 13–16. This gradual approach, called titration, reduces nausea, vomiting, and gastrointestinal discomfort that can occur when doses jump too quickly. Clinical trials show that slower titration improves medication tolerability and adherence rates.

Some patients benefit from staying at maintenance doses of 1.0 mg weekly for several months before their prescriber considers a step up to 1.7 mg or 2.4 mg. The timeline depends on your individual response, gastrointestinal tolerance, and weight loss progress. PlexusDx works with qualified prescribers who personalize your titration schedule based on your baseline health, metabolism, and medication history rather than applying a one-size-fits-all approach.

Why Semaglutide Dosing Increases Over Time

Your body adapts to semaglutide over weeks, a process called tachyphylaxis, where initial responses to a medication diminish as your system becomes accustomed to it. Gradual dose increases help maintain appetite suppression and metabolic benefits without overwhelming your digestive system. Research shows that jumping from 0.25 mg to 2.4 mg in one month causes significantly higher rates of side effects and dropout, whereas the four-month titration schedule keeps most patients engaged.

Semaglutide affects multiple hunger pathways in your brain and gut, including GLP-1 receptors and leptin signaling. Higher doses activate these pathways more completely, leading to greater calorie reduction and weight loss plateaus being overcome. Your prescriber monitors your response at each dose level to determine whether you're ready to advance or whether remaining at your current dose is appropriate for your goals.

Maintenance Doses and Long-Term Semaglutide Therapy

Once you reach your target dose—typically 1.0 mg, 1.7 mg, or 2.4 mg weekly—you enter the maintenance phase, where you take the same injection every seven days for as long as your prescriber recommends. Most patients see meaningful weight loss results within the first 12–16 weeks, with continued improvements over 6–12 months. Clinical data from GLP-1 trials demonstrate that sustained treatment, not just the titration phase, is essential for maintaining weight loss and preventing regain.

Long-term semaglutide use requires ongoing monitoring of your blood pressure, kidney function, and gastrointestinal symptoms. PlexusDx includes regular check-ins with your prescriber to assess how well your current dose is working and whether adjustments or additional support—like the Precision Peptide Genetic Test—might optimize your outcomes. Stopping semaglutide typically leads to gradual weight regain over months, so many patients continue maintenance therapy as part of their long-term weight management strategy.

Personalized Dosing and Genetic Predictors of Response

Not every patient needs the same dose to achieve results; your genetics, metabolism, appetite pathway sensitivity, and prior weight loss history all influence how your body responds. The GLP-1 receptor gene (GLP1R) and the FTO gene, which regulates appetite and energy balance, carry variants that predict how aggressively your hunger signals will decrease at each dose level. PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides to identify whether you carry genetic markers associated with high GLP-1 pathway sensitivity or insulin-resistance-driven weight gain.

Patients with certain GLP1R or GIPR variants may see strong appetite suppression at lower doses, allowing them to skip higher increments, while others with FTO or MC4R variants may require full titration to 2.4 mg to achieve comparable results. Understanding your genetic peptide profile helps your PlexusDx prescriber tailor your titration timeline and target dose, reducing trial-and-error adjustments and improving your confidence in the treatment plan. This precision approach transforms semaglutide from a one-size-fits-all medication into a personalized therapy aligned with your unique biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of semaglutide, and when do I take my first injection?

Your first semaglutide injection is 0.25 mg once weekly, taken on the same day each week for four weeks. PlexusDx prescribers provide detailed injection training and support to ensure comfort and confidence with your first dose. You can start your titration schedule immediately after your prescription is filled from a licensed 503A compounding pharmacy.

How long does it take to reach the full maintenance dose of semaglutide?

The standard titration schedule takes 16 weeks (four months) to progress from 0.25 mg to 1.0 mg maintenance dose. Some prescribers may extend this timeline if you experience side effects or adjust it based on your individual response. Clinical trials show this gradual approach produces the best tolerability and long-term adherence rates.

Can I skip doses or stop the titration schedule early?

Stopping or skipping doses is not recommended because your prescriber has designed your schedule to maximize weight loss while minimizing side effects. However, if you experience intolerable nausea or gastrointestinal issues, contact your PlexusDx prescriber immediately—they may slow your titration or adjust your injection timing rather than discontinue therapy. Never modify your dosing without guidance.

What happens if semaglutide side effects are severe during my dose increases?

Side effects like nausea typically improve within a few days as your body adjusts; eating smaller, lower-fat meals and staying hydrated help significantly. If severe nausea, vomiting, or abdominal pain persists, your PlexusDx prescriber can extend your stay at a lower dose, delay your next increase by one or two weeks, or recommend anti-nausea strategies. Severe side effects should never be ignored—contact your provider immediately.

Does the Precision Peptide Genetic Test predict which semaglutide dose I'll need?

Yes, the PlexusDx Precision Peptide Genetic Test identifies variants in your GLP1R, GIPR, FTO, and MC4R genes that correlate with appetite pathway sensitivity and weight loss potential. Patients with high-sensitivity GLP-1 receptor variants may achieve results at 1.0 mg, while others with lower sensitivity may need escalation to 1.7 or 2.4 mg. This genetic insight helps your prescriber set realistic expectations and personalize your titration strategy from day one.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves